|A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone||
||915||All||18 Years to 77 Years (Adult, Senior)||NCT00528879||MB102-014 LT
|September 2007||November 2008||May 2010||September 12, 2007||October 20, 2015||May 2, 2014||
|2||NCT02925559||Not yet recruiting||Effect of Anti-diabetic Drugs on Glycemic Variability||
||Other / Industry||
||120||All||40 Years and older (Adult, Senior)||NCT02925559||ESR-14-10377||EFFORT||October 2016||December 2017||December 2017||October 6, 2016||October 6, 2016||
† Study has passed its completion date and status has not been verified in more than two years.